INSP vs. BAX, SWAV, PODD, SOLV, TFX, GMED, PEN, GKOS, MMSI, and HAE
Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Baxter International (BAX), Shockwave Medical (SWAV), Insulet (PODD), Solventum (SOLV), Teleflex (TFX), Globus Medical (GMED), Penumbra (PEN), Glaukos (GKOS), Merit Medical Systems (MMSI), and Haemonetics (HAE). These companies are all part of the "surgical & medical instruments" industry.
Inspire Medical Systems (NYSE:INSP) and Baxter International (NYSE:BAX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability.
Inspire Medical Systems has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500.
Baxter International received 551 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 66.12% of users gave Baxter International an outperform vote while only 61.03% of users gave Inspire Medical Systems an outperform vote.
Baxter International has a net margin of 17.79% compared to Inspire Medical Systems' net margin of -2.38%. Baxter International's return on equity of 18.47% beat Inspire Medical Systems' return on equity.
Baxter International has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.
In the previous week, Baxter International had 12 more articles in the media than Inspire Medical Systems. MarketBeat recorded 18 mentions for Baxter International and 6 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.28 beat Baxter International's score of 0.46 indicating that Inspire Medical Systems is being referred to more favorably in the media.
94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Inspire Medical Systems presently has a consensus target price of $256.53, suggesting a potential upside of 61.46%. Baxter International has a consensus target price of $44.42, suggesting a potential upside of 30.22%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, equities research analysts clearly believe Inspire Medical Systems is more favorable than Baxter International.
Summary
Baxter International beats Inspire Medical Systems on 10 of the 18 factors compared between the two stocks.
Get Inspire Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inspire Medical Systems Competitors List
Related Companies and Tools
